The modulation of pancreatic lipase activity by alginates
Matthew D Wilcox, Iain A Brownlee, J Craig Richardson, Peter W Dettmar, Jeffrey P Pearson, Matthew D Wilcox, Iain A Brownlee, J Craig Richardson, Peter W Dettmar, Jeffrey P Pearson
Abstract
Alginates are comprised of mannuronic (M) and guluronic acid (G) and have been shown to inhibit enzyme activity. Pancreatic lipase is important in dietary triacylglycerol breakdown; reducing pancreatic lipase activity would reduce triacylglycerol breakdown resulting in lower amounts being absorbed by the body. Lipase activity in the presence of biopolymers was assessed by enzymatic assay using natural and synthetic substrates. Alginate inhibited pancreatic lipase by a maximum of 72.2% (±4.1) with synthetic substrate (DGGR) and 58.0% (±9.7) with natural substrate. High-G alginates from Laminaria hyperborea seaweed inhibited pancreatic lipase to a significantly higher degree than High-M alginates from Lessonia nigrescens, showing that inhibition was related to alginate structure. High-G alginates are effective inhibitors of pancreatic lipase and are used in the food industry at low levels. They could be included at higher levels in foods without altering organoleptic qualities, potentially reduce the uptake of dietary triacylglycerol aiding in weight management.
Keywords: Alginate; Inhibition; Lipase; Obesity; Weight management.
Copyright © 2013 Elsevier Ltd. All rights reserved.
Figures
References
- Borgstrom B. Mode of action of tetrahydrolipstatin – a derivative of the naturally-occurring lipase inhibitor lipstatin. Biochimica et Biophysica Acta. 1988;962(3):308–316. [Article]
- Cavaliere H., Floriano I., Medeiros-Neto G. Gastrointestinal side effects of orlistat may be prevented by concomitant prescription of natural fibers (Psyllium mucilloid) International Journal of Obesity. 2001;25(7):1095–1099. [Proceedings Paper]
- Drent M.L., Vanderveen E.A. Lipase inhibition – a novel concept in the treatment of obesity. International Journal of Obesity. 1993;17(4):241–244.
- Gursoy A., Erdogan M.F., Cin M.O., Cesur M., Baskal N. Comparison of orlistat and sibutramine in an obesity management program: Efficacy, compliance, and weight regain after noncompliance. Eating and Weight Disorders. 2006;11(4):127–132.
- Hadvary P., Lengsfeld H., Wolfer H. Inhibition of pancreatic lipase invitro by the covalent inhibitor tetrahydrolipstatin. Biochemical Journal. 1988;256(2):357–361. [Article]
- Hamosh M., Scow R.O. Lingual lipase and its role in digestion of dietary lipid. Journal of Clinical Investigation. 1973;52(1):88–95.
- Han L.K., Kimura Y., Okuda H. Reduction in fat storage during chitin–chitosan treatment in mice fed a high-fat diet. International Journal of Obesity. 1999;23(2):174–179.
- Haug A., Smidsrod O. Strontium–calcium selectivity of alginates. Nature. 1967;215(5102):757.
- Isaksson G., Lundquist I., Ihse I. In vitro inhibition of pancreatic enzyme activities by dietary fiber. Digestion. 1982;24(1):54–59.
- Jemel I., Fendri A., Gargouri Y., Bezzine S. Kinetic properties of dromedary pancreatic lipase: A comparative study on emulsified and monomolecular substrate. Colloids and Surfaces B. 2009;70(2):238–242.
- Kumar A., Chauhan G.S. Extraction and characterization of pectin from apple pomace and its evaluation as lipase (steapsin) inhibitor. Carbohydrate Polymers. 2010;82(2):454–459.
- Malone M., Alger-Mayer S.A. Pharmacist intervention enhances adherence to orlistat therapy. Annals of Pharmacotherapy. 2003;37(11):1598–1602.
- Mu H., Høy C.-E. The digestion of dietary triacylglycerols. Progress in Lipid Research. 2004;43(2):105–133.
- Panteghini M., Bonora R., Pagani F. Measurement of pancreatic lipase activity in serum by a kinetic colorimetric assay using a new chromogenic substrate. Annals of Clinical Biochemistry. 2001;38:365–370.
- Rogalska E., Ransac S., Verger R. Stereoselectivity of lipases. II. Stereoselective hydrolysis of triglycerides by gastric and pancreatic lipases. Journal of Biological Chemistry. 1990;265(33):20271–20276.
- Sandberg A.S., Andersson H., Bosaeus I., Carlsson N.G., Hasselblad K., Harrod M. Alginate, small-bowel sterol excretion, and absorption of nutrients in ileostomy subjects. American Journal of Clinical Nutrition. 1994;60(5):751–756.
- Strugala V., Kennington E.J., Campbell R.J., Skjak-Braek G., Dettmar P.W. Inhibition of pepsin activity by alginates in vitro and the effect of epimerization. International Journal of Pharmaceutics. 2005;304(1–2):40–50.
- Sunderland A.M., Dettmar P.W., Pearson J.P. Alginates inhibit pepsin activity in vitro; A justification for their use in gastro-oesophageal reflux disease (GORD) Gastroenterology. 2000;118(4):347.
- Taylor C., Draget K.I., Pearson J.P., Smidsrød O. Mucous systems show a novel mechanical response to applied deformation. Biomacromolecules. 2005;6(3):1524–1530.
- Taylor C., Pearson J.P., Draget K.I., Dettmar P.W., Smidsrød O. Rheological characterisation of mixed gels of mucin and alginate. Carbohydrate Polymers. 2005;59(2):189–195.
- The NHS Information Centre, L. S. (2012). Statistics on obesity, physical activity and diet – England, 2012.
- Tsujita T., Takaichi H., Takaku T., Sawai T., Yoshida N., Hiraki J. Inhibition of lipase activities by basic polysaccharide. Journal of Lipid Research. 2007;48(2):358–365.
- Vogel W.C., Zieve L. A rapid and sensitive turbidimetric method for serum lipase based upon differences between the lipases of normal and pancreatitis serum. Clinical Chemistry. 1963;9(2):168–181.
- Zhi J., Melia A.T., Guerciolini R., Chung J., Kinberg J., Hauptman J.B. Retrospective population-based analysis of the dose-response (fecal fat excretion) relationship of orlistat in normal and obese volunteers. Clinical Pharmacology and Therapeutics. 1994;56(1):82–85.
Source: PubMed